| Patent | Date |
|---|
Modified Antibodies And Methods Of Use
App 20110020222 - Braslawsky; Gary R. ; et al. | 2011-01-27 |
Expression and use of anti-CD20 Antibodies
Grant 7,744,877 - Anderson , et al. June 29, 2 | 2010-06-29 |
Recombinant Anti-cd4 Antibodies For Human Therapy
App 20090226430 - HANNA; Nabil ; et al. | 2009-09-10 |
Recombinant Anti-cd4 Antibodies For Human Therapy
App 20090221036 - Hanna; Nabil ; et al. | 2009-09-03 |
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens
App 20090124791 - Anderson; Darrell R. ; et al. | 2009-05-14 |
Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies
Grant 7,510,712 - Anderson , et al. March 31, 2 | 2009-03-31 |
Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies
Grant 7,510,713 - Anderson , et al. March 31, 2 | 2009-03-31 |
Methods of producing 7C10 and 16C10 CD80-specific antibodies
Grant 7,501,264 - Anderson , et al. March 10, 2 | 2009-03-10 |
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies
Grant 7,491,393 - Anderson , et al. February 17, 2 | 2009-02-17 |
Modified Antibodies And Methods Of Use
App 20090022658 - Braslawsky; Gary R. ; et al. | 2009-01-22 |
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens
App 20090012271 - Anderson; Darrell R. ; et al. | 2009-01-08 |
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens
App 20090010939 - Anderson; Darrell R. ; et al. | 2009-01-08 |
Recombinant anti-CD4 antibodies for human therapy
Grant 7,452,534 - Hanna , et al. November 18, 2 | 2008-11-18 |
Immunoregulatory Antibodies And Uses Thereof
App 20080227198 - Hariharan; Kandasamy ; et al. | 2008-09-18 |
Immunoregulatory Antibodies And Uses Thereof
App 20080226626 - Hariharan; Kandasamy ; et al. | 2008-09-18 |
Host cells expressing 7C10 and 16C10 CD80-specific antibodies
Grant 7,425,447 - Anderson , et al. September 16, 2 | 2008-09-16 |
Anti-CD20 antibodies
Grant 7,422,739 - Anderson , et al. September 9, 2 | 2008-09-09 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080213167 - Hariharan; Kandasamy ; et al. | 2008-09-04 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080213168 - Hariharan; Kandasamy ; et al. | 2008-09-04 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080213260 - Hariharan; Kandasamy ; et al. | 2008-09-04 |
7C10 and 16C10 CD80-specific antibodies
Grant 7,417,128 - Anderson , et al. August 26, 2 | 2008-08-26 |
Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies
Grant 7,414,123 - Anderson , et al. August 19, 2 | 2008-08-19 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20080171056 - Hariharan; Kandasamy ; et al. | 2008-07-17 |
Expression and use of anti-CD20 antibodies
Grant 7,381,560 - Anderson , et al. June 3, 2 | 2008-06-03 |
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens
App 20080114156 - Anderson; Darrell R. ; et al. | 2008-05-15 |
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens
App 20080095769 - Anderson; Darrell R. ; et al. | 2008-04-24 |
Therapeutic Application Of Chimeric And Radiolabelled Antibodies To Human B Lymphocyte Restricted Differentiation Antigen For Treatment Of B Cell Lymphoma
App 20080089893 - Anderson; Darrell R. ; et al. | 2008-04-17 |
Recombinant anti-CD4 antibodies for human therapy
Grant 7,338,658 - Hanna , et al. March 4, 2 | 2008-03-04 |
Identification of Unique Binding Interactions Between Certain Antibodies and the Human B7.1 and B7.2 Co-Stimulatory Antigens
App 20080038254 - Anderson; Darrell R. ; et al. | 2008-02-14 |
Anti-CD80 antibodies
Grant 7,323,170 - Anderson , et al. January 29, 2 | 2008-01-29 |
TAG-72 specific C.sub.H2 domain deleted antibodies
Grant 7,319,139 - Braslawsky , et al. January 15, 2 | 2008-01-15 |
Tag-72 Specific Ch2 Domain Deleted Antibodies
App 20070280881 - Braslawsky; Gary R. ; et al. | 2007-12-06 |
Method for preparing anti-MIF antibodies
Grant 7,294,753 - Kloetzer , et al. November 13, 2 | 2007-11-13 |
Identification Of Unique Binding Interactions Between Certain Antibodies And The Human B7.1 And B7.2 Co-stimulatory Antigens
App 20070128185 - Anderson; Darrell R. ; et al. | 2007-06-07 |
Anti-cd80 Antibody Having Adcc Activity For Adcc Mediated Killing Of B Cell Lymphoma Cells Alone Or In Combination With Other Therapies
App 20070065436 - Hariharan; Kandasamy ; et al. | 2007-03-22 |
CD80 specific antibodies
Grant 7,192,585 - Anderson , et al. March 20, 2 | 2007-03-20 |
Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4
Grant 7,175,847 - Anderson , et al. February 13, 2 | 2007-02-13 |
Immunoregulatory Antibodies and Uses Thereof
App 20070009519 - Hariharan; Kandasamy ; et al. | 2007-01-11 |
Combination Therapy For Treatment Of Autoimmune Diseases Using B- Cell Depleting/immunoregulatory Antibody Combination
App 20070003544 - Hanna; Nabil | 2007-01-04 |
Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4
Grant 7,153,508 - Anderson , et al. December 26, 2 | 2006-12-26 |
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
App 20060286100 - Hariharan; Kandasamy ; et al. | 2006-12-21 |
Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
App 20060286101 - Hariharan; Kandasamy ; et al. | 2006-12-21 |
Identification of Unique Binding Interactions Between Certain Antibodies and the Human B7.1 and B7.2 Co-Stimulatory Antigens
App 20060275291 - Anderson; Darrell R. ; et al. | 2006-12-07 |
Combination Therapy For Treatment Of Autoimmune Diseases Using B-cell Depleting/immunoregulatory Antibody Combination
App 20060275284 - Hanna; Nabil | 2006-12-07 |
Treating autoimmune diseases with humanized anti-CD40L antibody
Grant 7,122,187 - Black , et al. October 17, 2 | 2006-10-17 |
Method for preparing anti-MIF antibodies
App 20060191024 - Kloetzer; William S. ; et al. | 2006-08-24 |
Use Of Cd23 Antagonists For The Treatment Of Neoplastic Disorders
App 20060171950 - Hariharan; Kandasamy ; et al. | 2006-08-03 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20060153848 - Hanna; Nabil ; et al. | 2006-07-13 |
Treating autoimmune diseases with humanized anti-CD401 antibodies
App 20060153837 - Black; Amelia ; et al. | 2006-07-13 |
Treating allergic diseases with humanized anti-CD40L antibody
Grant 7,074,406 - Black , et al. July 11, 2 | 2006-07-11 |
Humanized antibodies to human GP39, compositions, and therapeutic uses thereof
App 20060147446 - Black; Amelia ; et al. | 2006-07-06 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
Grant 6,998,125 - Hanna , et al. February 14, 2 | 2006-02-14 |
Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens and therapy thereof
App 20050260205 - Anderson, Darrell R. ; et al. | 2005-11-24 |
Therapeutic application of chimeric and radiolabeled antibodies to human B Lymphocyte restricted differentiation antigen for treatment of B cell Lymphoma
App 20050186205 - Anderson, Darrell R. ; et al. | 2005-08-25 |
Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
App 20050180975 - Hanna, Nabil | 2005-08-18 |
Production of tetravalent antibodies
App 20050158828 - Braslawsky, Gary R. ; et al. | 2005-07-21 |
Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants
App 20050129688 - Anderson, Darrell R. ; et al. | 2005-06-16 |
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
App 20050123540 - Hanna, Nabil ; et al. | 2005-06-09 |
Production of tetravalent antibodies
Grant 6,897,044 - Braslawsky , et al. May 24, 2 | 2005-05-24 |
Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
Grant 6,896,885 - Hanna May 24, 2 | 2005-05-24 |
Methods for treating b cell lymphoma using CD80-specific antibodies
Grant 6,893,638 - Anderson , et al. May 17, 2 | 2005-05-17 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20040137014 - Hanna, Nabil ; et al. | 2004-07-15 |
Treatment of psoriasis using anti-B7.1 (CD80) antibodies
Grant 6,709,654 - Anderson , et al. March 23, 2 | 2004-03-23 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Grant 6,682,734 - Anderson , et al. January 27, 2 | 2004-01-27 |
Method for preparing anti-MIF antibodies
App 20030235584 - Kloetzer, William S. ; et al. | 2003-12-25 |
Use of CD23 antagonists for the treatment of neoplastic disorders
App 20030211107 - Hariharan, Kandasamy ; et al. | 2003-11-13 |
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
App 20030180292 - Hanna, Nabil ; et al. | 2003-09-25 |
Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies
App 20030180290 - Hariharan, Kandasamy ; et al. | 2003-09-25 |
Humanized antibodies to human gp39, compositions containing and therapeutic use thereof
App 20030175269 - Black, Amelia ; et al. | 2003-09-18 |
Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
App 20030170233 - Black, Amelia ; et al. | 2003-09-11 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
App 20030147885 - Anderson, Darrell R. ; et al. | 2003-08-07 |
Immunoregulatory antibodies and uses thereof
App 20030103971 - Hariharan, Kandasamy ; et al. | 2003-06-05 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restriced differentiation antigen for treatment of B cell lymphoma
App 20030095963 - Anderson, Darrell R. ; et al. | 2003-05-22 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
App 20030082172 - Anderson, Darrell R. ; et al. | 2003-05-01 |
Recombinant anti-CD4 antibodies for human therapy
App 20030077275 - Hanna, Nabil ; et al. | 2003-04-24 |
Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
App 20030021781 - Anderson, Darrell R. ; et al. | 2003-01-30 |
Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
App 20030012781 - Darrell, Anderson ; et al. | 2003-01-16 |
Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies
Grant 6,506,383 - Black , et al. January 14, 2 | 2003-01-14 |
Therapeutic application of chimeric and radiolabelled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
App 20020197255 - Anderson, Darrell R. ; et al. | 2002-12-26 |
Bispecific fusion protein and method of use for enhancing effector cell killing of target cells
App 20020193569 - Hanna, Nabil | 2002-12-19 |
Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
App 20020187146 - Anderson, Darrell R. ; et al. | 2002-12-12 |
Use of CD23 antagonists for the treatment of neoplastic disorders
App 20020159996 - Hariharan, Kandasamy ; et al. | 2002-10-31 |
Recombinant antibodies for human therapy
App 20020150580 - Newman, Roland A. ; et al. | 2002-10-17 |
Methods of treating autoimmune diseases with gp39-specific antibodies
Grant 6,440,418 - Black , et al. August 27, 2 | 2002-08-27 |
Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma
Grant 6,399,061 - Anderson , et al. June 4, 2 | 2002-06-04 |
Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory antibody combination
App 20020058029 - Hanna, Nabil | 2002-05-16 |
Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
App 20020028178 - Hanna, Nabil ; et al. | 2002-03-07 |
Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
App 20020012665 - Hanna, Nabil | 2002-01-31 |
Treatment of cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
App 20020006404 - Hanna, Nabil ; et al. | 2002-01-17 |
Monkey monoclonal antibodies specific to human B7.1 and/or B7.2, primatized forms thereof, pharmaceutical compositions containing, and use thereof as immunosuppressants
App 20010024648 - Anderson, Darrell R. ; et al. | 2001-09-27 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20010019715 - Hanna, Nabil ; et al. | 2001-09-06 |
Treatment of B cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
App 20010018041 - Hanna, Nabil ; et al. | 2001-08-30 |
Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis
App 20010018054 - Hanna, Nabil ; et al. | 2001-08-30 |
Recombinant anti-CD4 antibodies for human therapy
Grant 6,136,310 - Hanna , et al. October 24, 2 | 2000-10-24 |
Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
Grant 6,113,898 - Anderson , et al. September 5, 2 | 2000-09-05 |
Humanized antibodies to human gp39, compositions containing thereof
Grant 6,001,358 - Black , et al. December 14, 1 | 1999-12-14 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Grant 5,843,439 - Anderson , et al. December 1, 1 | 1998-12-01 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Grant 5,776,456 - Anderson , et al. July 7, 1 | 1998-07-07 |
Recombinant antibodies for human therapy
Grant 5,756,096 - Newman , et al. May 26, 1 | 1998-05-26 |
Recombinant antibodies for human therapy
Grant 5,750,105 - Newman , et al. May 12, 1 | 1998-05-12 |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Grant 5,736,137 - Anderson , et al. April 7, 1 | 1998-04-07 |
Recombinant antibodies for human therapy
Grant 5,693,780 - Newman , et al. December 2, 1 | 1997-12-02 |
Recombinant antibodies for human therapy
Grant 5,681,722 - Newman , et al. October 28, 1 | 1997-10-28 |
Recombinant antibodies for human therapy
Grant 5,658,570 - Newman , et al. August 19, 1 | 1997-08-19 |
Inhibition of interleukin-1 and tumor necrosis factor production by monocytes and/or macrophages
Grant 5,317,019 - Bender , et al. May 31, 1 | 1994-05-31 |
Pyrrolo [1,2-a] imidazole and imidazo [1,2a] pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
Grant 5,145,858 - Adams , et al. September 8, 1 | 1992-09-08 |
Pyrrolo(1,2-a)imidazole and imidazo(1,2-a)pyridine derivatives and their use as 5-lipoxygenase pathway inhibitors
Grant 5,002,941 - Adams , et al. March 26, 1 | 1991-03-26 |
Inhibition of interleukin-1 production by monocytes and/or macrophages
Grant 4,794,114 - Bender , et al. December 27, 1 | 1988-12-27 |
Inhibition of interleukin-1 by monocytes and/or macrophages
Grant 4,780,470 - Bender , et al. October 25, 1 | 1988-10-25 |
Inhibition of interleukin-1 production by monocytes and/or macrophages
Grant 4,778,806 - Bender , et al. October 18, 1 | 1988-10-18 |
Inhibition of 5-lipoxygenase products
Grant 4,686,231 - Bender , et al. August 11, 1 | 1987-08-11 |
| 